Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human epidermal growth factor for diabetic foot ulcers (Wagner 3–4)
CTR20140502Phase 3Active
- Sponsor
- Center for Genetic Engineering and Biotechnology
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of nepidermin in diabetic foot ulcer (DFU), sponsored by Center for Genetic Engineering and Biotechnology. Started Aug 2014; status: active.
02
Drugs
nepidermin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on CTR20140502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140502.